Range of proportions of patients with asthma and/or COPD for whom EMRs contained any of selected variables
Country | EMR source | Age/sex, % | Height/weight, % | Lung function tests, % | Haemat-ology tests, % | PROs,% |
---|---|---|---|---|---|---|
Australia | A (GPs) | 100 | 21−32 | 0 | 31−66 | 0 |
Canada | A | 100 | 34−42 | 1−10 | 38−52 | 0 |
China | B (outpatient) | 100 | 0 | 0 | 2–83 | 0 |
France | A | 99–100 | 13−46 | 0 | 7–19 | 0 |
Germany | A | 100 | 18−23 | 0 | 0 | 0 |
Italy | A | 79–100 | 18−24 | 0–4 | 13–23 | 0 |
Japan | B | 100 | 0 | 0 | 0 | 0 |
Spain | A | 100 | 24−41 | 0 | 26–35 | 0 |
Sweden | C | 100 | 34−55 | 33−56 | NA | 0 |
UK | A (GPs) | 100 | 30−72 | 0−57 | 31−59 | 0 |
USA | A, C | 100 | 32−100 | 0−17 | 10−>70 | 0 |
A, physician records; B, hospital records; C, registries; COPD, chronic obstructive pulmonary disease; EMR, electronic medical record; GP, general practitioner; NA, available but not assessed; PROs, patient-reported outcomes.
Please refer to page A271 for declarations of interest in relation to abstract P138.